Private equity giant KKR & Co. is working with advisers to evaluate a potential sale of LGC Group, Bloomberg News reported, citing people familiar with the matter.
A sale could bring more than £1 billion for the U.K.-based life-sciences testing company, the people told the news outlet. KKR is in the early stage of deliberations and could still opt against a sale, they added.
KKR acquired LGC from British buyout firm Bridgepoint Advisers Ltd. in a deal completed in 2016. LGC, formerly known as Laboratory of the Government Chemist, was first taken private in 1996.
A KKR spokesman declined to comment, according to Bloomberg.